Hashimoto’s thyroiditis is a chronic autoimmune disease that primarily affects the thyroid gland, leading to progressive hypothyroidism. The condition occurs when the body’s immune system produces antibodies that attack thyroid tissue, resulting in inflammation and impaired hormonal function. Diagnosis is based on clinical symptoms, elevated TSH levels, low free thyroxine, and the presence of anti-thyroid antibodies. Treatment typically involves lifelong hormone replacement therapy with levothyroxine to normalize metabolic function.

Hashimoto’s thyroiditis, autoimmune disease, hypothyroidism, thyroid antibodies, levothyroxine therapy, endocrine disorders.

Weetman, A. P. (2000). Autoimmune thyroid disease: propagation and progression. European Journal of Endocrinology, 143(1), 1–4.

Caturegli, P., De Remigis, A., & Rose, N. R. (2014). Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmunity Reviews, 13(4-5), 391–397.

Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A., & Fallahi, P. (2015). Autoimmune thyroid disorders. Autoimmunity Reviews, 14(2), 174–180.

American Thyroid Association. (2017). Guidelines for the treatment of hypothyroidism. Thyroid, 27(6), 1–15.

Mazokopakis, E. E., et al. (2011). Effects of 12 months' treatment with L-selenomethionine on serum anti-TPO antibodies in patients with Hashimoto's thyroiditis. Thyroid, 21(4), 359–363.

Khamidova, Sh.Sh. (2018). The prevalence and clinical course of autoimmune thyroiditis in women of reproductive age. Uzbek Medical Journal, (1), 45–49.

Rasulova, Z.A. (2019). Diagnostic value of thyroid ultrasound in Hashimoto’s thyroiditis. Tashkent Medical Academy Journal, (3), 60–64.

Mavlonova, M.A. (2021). Comorbid autoimmune conditions in patients with chronic thyroiditis. Endocrinology of Uzbekistan, (2), 33–38.